A Phase III, Multicentre, Randomized, Double-blind Parallel-group Study to Evaluate the Safety and Clinical Outcome of Once Daily Esomeprazole for the Treatment of Gastroesophageal Reflux Disease GERD in Pediatric Patients 1 to 11 Years of Age, Inclusive

Registry ID

EUCTR2004-002370-39

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

ASTRAZENECA

Start date

2004-12-02

Last update

2026-08-16

Conditions

• Gastroesophageal Reflux Disease GERD
• Gastroesophageal Reflux Disease

Summary

Gastroesophageal Reflux Disease GERD

Locations

• , , Italy

Related clinical trials

• Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health Impacts
• A Retrospective Analysis of Patients With Gastroesophageal Reflux Disease Based on a Prospective Clinical Dataset
• Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
• Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)
• Domperidone in Treating Patients With Gastrointestinal Disorders
• Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer

View on source registry